NCT06509334 - Trial of JYB1904 in Chronic Spontaneous Urticaria. | Biotech Hunter

Enrollment

135

Participants

Timeline

Start Date

August 4, 2024

Primary Completion Date

July 15, 2026

Study Completion Date

July 15, 2026

Conditions

Chronic Spontaneous Urticaria

Interventions

DRUG

JYB1904

Participants will receive JYB1904 at week0 and receive placebo at week4,8,12

DRUG

JYB1904

Participants will receive JYB1904 at week0,8 and receive placebo at week4,12

DRUG

Omalizumab

Participants will receive Omalizumab every 4 weeks for 12 weeks

Trial Locations (1)

RECRUITING

Peking University People's Hospital, Beijing